Benefit-Risk Assessment Methodology Workshop - Programme Agenda
Introduction - Benefit-Risk Modelling of Pharmaceuticals: Where are we now? - Professor Lawrence Phillips - London School of Economics
Quantitative Methods Across the Product Lifecycle - A Personal Perspective - Andrew Thompson -MHRA
Comparison of different Benefit-Risk methodologies - Professor Johan Bring - Statisticon AB
A Structured Approach with Focus on Transparency, Clinical Significance and Visualization - Dr. Sinan B. Sarac - Danish Health and Medicines Authority
Post-marketing surveillance of drug safety in 2012: The EU Regulatory Framework - Dr. Doris Stenver - Danish Health and Medicines Authority
Cost/Benefit evaluations in road safety...and in pharmaceutical pricing and reimbursement - Professor Ulf Persson - Swedish Institute of Health Economics
Benefit-Risk Modelling of Pharmaceuticals: Where are we going? - Professor Lawrence Phillips